Gentel Biosciences

Gentel's GlycoBiomarker Technology uses lectin-based glycan affinity reagents and antibody microarrays in a completely novel approach to biomarker profiling. Gentel has developed a 46-plex antibody array in a 96-well format to measure changes in both the glycosylation and concentration of specific cancer biomarker proteins in patient serum samples.

For more information, contact Gentel Biosciences
www.gentelbio.com/, 608-441-2904 or
866-441-8199
Visit us at AACR Booth number #769